المؤلفون: Nicolas Penel, Bruno Chauffert, Elodie Vauleon, Alice Bonneville-Levard, Jean-Yves Blay, Christine Chevreau, Didier Cupissol, Olivier Mir, Esma Saada-Bouzid, Axel Le Cesne, Jacques-Olivier Bay, Loïc Feuvret, Florence Duffaud, Georges Noël, François Bertucci, Loïc Lebellec, Michel Fabbro, Emmanuelle Bompas, Armelle Vinceneux

المساهمون: CHU Amiens-Picardie, Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Département de médecine oncologique [Gustave Roussy], Institut Gustave Roussy (IGR), Institut Claudius Regaud, CRLCC René Gauducheau, Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Institut de Recherche sur le Cancer et le Vieillissement (IRCAN), Université Nice Sophia Antipolis (1965 - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Côte d'Azur (UCA), Medical Oncology Unit, S. Camillo-Forlanini Hospital, Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière (CRICM), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Role of intra-Clonal Heterogeneity and Leukemic environment in ThErapy Resistance of chronic leukemias (CHELTER), Université Clermont Auvergne [2017-2020] (UCA [2017-2020]), CRLCC Eugène Marquis (CRLCC), Centre Paul Strauss, CRLCC Paul Strauss, Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] (UNICANCER/Lille), Université de Lille-UNICANCER, Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Equipe 11, Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Aix Marseille Université (AMU), Université Nice Sophia Antipolis (... - 2019) (UNS), Université Lille Nord de France (COMUE)-UNICANCER

المصدر: European Journal of Cancer
European Journal of Cancer, 2017, 79, pp.119-128. ⟨10.1016/j.ejca.2017.03.037⟩
European Journal of Cancer, Elsevier, 2017, 79, pp.119-128. ⟨10.1016/j.ejca.2017.03.037⟩

مصطلحات موضوعية: Male, Oncology, Cancer Research, Indoles, 0302 clinical medicine, Sunitinib, Molecular Targeted Therapy, Child, ComputingMilieux_MISCELLANEOUS, Aged, 80 and over, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, Middle Aged, Sorafenib, Temsirolimus, 3. Good health, Treatment Outcome, 030220 oncology & carcinogenesis, Imatinib Mesylate, Female, France, Erlotinib, medicine.drug, Adult, Niacinamide, medicine.medical_specialty, Adolescent, Antineoplastic Agents, Skull Base Neoplasms, Erlotinib Hydrochloride, Young Adult, 03 medical and health sciences, Internal medicine, Chordoma, medicine, Humans, Pyrroles, Aged, Retrospective Studies, Sirolimus, business.industry, Phenylurea Compounds, Neurooncology, Retrospective cohort study, medicine.disease, Surgery, business, 030217 neurology & neurosurgery, Progressive disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c8bd1a039b6bb9199ecaab513b64ce4Test
https://doi.org/10.1016/j.ejca.2017.03.037Test

المؤلفون: Biancari, Fausto, Ruggieri, Vito G., Perrotti, Andrea, Svenarud, Peter, Dalén, Magnus, Onorati, Francesco, Faggian, Giuseppe, Santarpino, Giuseppe, Maselli, Daniele, Dominici, Carmelo, Nardella, Saverio, Musumeci, Francesco, Gherli, Riccardo, Mariscalco, Giovanni, Masala, Nicola, Rubino, Antonino S., Mignosa, Carmelo, de Feo, Marisa, Della Corte, Alessandro, Bancone, Ciro, Chocron, Sidney, Gatti, Giuseppe, Gherli, Tiziano, Kinnunen, Eeva-Maija, Juvonen, Tatu

المساهمون: Oulu University Hospital Oulu, CHU Pontchaillou Rennes, Karolinska University Hospital Stockholm, University Hospital of Verona, Paracelsus Medizinische Privatuniversität = Paracelsus Medical University (PMU), St Anna Hospital, S. Camillo-Forlanini Hospital, University Hospitals Leicester, Morgagni-Pierantoni Hospital, University of Naples Federico II = Università degli studi di Napoli Federico II, Marqueurs pronostiques et facteurs de régulations des pathologies cardiaques et vasculaires - UFC ( UR 3920) (PCVP / CARDIO), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté COMUE (UBFC)-Université Bourgogne Franche-Comté COMUE (UBFC)

المصدر: ISSN: 1749-8090 ; Journal of Cardiothoracic Surgery ; https://hal-univ-rennes1.archives-ouvertes.fr/hal-01301146Test ; Journal of Cardiothoracic Surgery, 2015, 10, pp.90. ⟨10.1186/s13019-015-0292-z⟩.

مصطلحات موضوعية: Coronary artery bypass, Europe, Humans, Incidence, Middle Aged, Myocardial Infarction, Postoperative Complications, Prospective Studies, Registries, Risk Factors, Survival Rate, Time Factors, Treatment Outcome, [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26123033; hal-01301146; https://hal-univ-rennes1.archives-ouvertes.fr/hal-01301146Test; PUBMED: 26123033; PUBMEDCENTRAL: PMC4485338

الإتاحة: https://doi.org/10.1186/s13019-015-0292-zTest
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01301146Test

المؤلفون: Daniele Maselli, Vito G. Ruggieri, Alessandro Della Corte, Magnus Dalén, Tatu Juvonen, Giuseppe Faggian, Giuseppe Santarpino, Peter Svenarud, Riccardo Gherli, Saverio Nardella, Fausto Biancari, Francesco Onorati, Eeva-Maija Kinnunen, Carmelo Dominici, Francesco Musumeci, Giuseppe Gatti, Andrea Perrotti, Carmelo Mignosa, Giovanni Mariscalco, Marisa De Feo, Nicola Masala, Sidney Chocron, Ciro Bancone, Antonino S. Rubino, Tiziano Gherli

المساهمون: Biancari, Fausto, Ruggieri, Vito G., Perrotti, Andrea, Svenarud, Peter, Dalén, Magnu, Onorati, Francesco, Faggian, Giuseppe, Santarpino, Giuseppe, Maselli, Daniele, Dominici, Carmelo, Nardella, Saverio, Musumeci, Francesco, Gherli, Riccardo, Mariscalco, Giovanni, Masala, Nicola, Rubino, Antonino, Mignosa, Carmelo, DE FEO, Marisa, DELLA CORTE, Alessandro, Bancone, Ciro, Chocron, Sidney, Gatti, Giuseppe, Gherli, Tiziano, Kinnunen, Eeva Maija, Juvonen, Tatu, Oulu University Hospital [Oulu], CHU Pontchaillou [Rennes], Karolinska University Hospital [Stockholm], University Hospital of Verona, Paracelsus Medical University, St Anna Hospital, S. Camillo-Forlanini Hospital, University Hospitals Leicester, Morgagni-Pierantoni Hospital, Università degli studi di Napoli Federico II, Marqueurs pronostiques et facteurs de régulations des pathologies cardiaques et vasculaires - UFC ( PCVP / CARDIO ), Université Bourgogne Franche-Comté ( UBFC ) -Université de Franche-Comté ( UFC ) -Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ), Paracelsus Medizinische Privatuniversität = Paracelsus Medical University (PMU), Marqueurs pronostiques et facteurs de régulations des pathologies cardiaques et vasculaires - UFC ( EA 3920) (PCVP / CARDIO), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), University of Naples Federico II = Università degli studi di Napoli Federico II, Marqueurs pronostiques et facteurs de régulations des pathologies cardiaques et vasculaires - UFC ( UR 3920) (PCVP / CARDIO)

المصدر: Journal of Cardiothoracic Surgery
Journal of Cardiothoracic Surgery, BioMed Central, 2015, 10, pp.90. 〈10.1186/s13019-015-0292-z〉
Journal of Cardiothoracic Surgery, BioMed Central, 2015, 10, pp.90. ⟨10.1186/s13019-015-0292-z⟩
Journal of Cardiothoracic Surgery, 2015, 10, pp.90. ⟨10.1186/s13019-015-0292-z⟩

مصطلحات موضوعية: Registrie, Time Factors, [SDV]Life Sciences [q-bio], Myocardial Infarction, Coronary artery bypass grafting, 030204 cardiovascular system & hematology, law.invention, Study Protocol, 0302 clinical medicine, Postoperative Complications, Randomized controlled trial, law, Risk Factors, Medicine, 030212 general & internal medicine, Myocardial infarction, Prospective Studies, Registries, E-CABG, Coronary Artery Bypass, Prospective cohort study, Stroke, CABG, Incidence, General Medicine, Middle Aged, 3. Good health, Cardiac surgery, Survival Rate, Europe, Treatment Outcome, Cardiothoracic surgery, Middle Aged Myocardial Infarction, Cardiology and Cardiovascular Medicine, Human, Pulmonary and Respiratory Medicine, medicine.medical_specialty, complications, Time Factor, complication, 03 medical and health sciences, Risk Factors Survival Rate, Humans, Adverse effect, Survival rate, [ SDV ] Life Sciences [q-bio], business.industry, Coronary Artery Bypa, Risk Factor, medicine.disease, Surgery, Prospective Studie, Coronary Artery Bypass, Europe, Humans, Incidence, Middle Aged Myocardial Infarction, Postoperative Complications, Prospective Studies, Risk Factors Survival Rate, Time Factors, Treatment Outcome, Registries, Emergency medicine, Postoperative Complication, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e44f5df78262d377887e3189eb4ad8adTest
http://hdl.handle.net/11562/970004Test

المؤلفون: Véronique Brouste, Jean-Yves Blay, Aurélien de Reyniès, Carlo Lucchesi, Pauline Lagarde, Dominique Vince-Ranchère, Audrey Kauffmann, Agnès Leroux, F. Collin, Alain Aurias, Sébastien Salas, Franck Tirode, Philippe Terrier, Binh Bui, Jean-Michel Coindre, Louis Guillou, Sylvie Bonvalot, Frédéric Chibon, Gaëlle Pérot, Axel Le Cesne

المساهمون: TIRODE, Franck, Validation et identification de nouvelles cibles en oncologie (VINCO), Institut Bergonié [Bordeaux], UNICANCER-UNICANCER-Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), UNICANCER, Medical Oncology Unit, S. Camillo-Forlanini Hospital, Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Unité de génétique et biologie des cancers (U830), Université Paris Descartes - Paris 5 (UPD5)-Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), (le programme) Cartes d'identité des tumeurs (CIT), Ligue Nationales Contre le Cancer (LNCC), Département d'oncologie médicale, UNICANCER-UNICANCER, Département de biologie et pathologie médicales [Gustave Roussy], Institut Gustave Roussy (IGR), Centre d'Investigation Clinique en Biotherapie des cancers (CIC 1428 , CBT 507 ), Institut Gustave Roussy (IGR)-Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Département de médecine oncologique [Gustave Roussy], Centre Léon Bérard [Lyon], Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), Oncology - Pathology - Anatomy, Institute of Pathology-University of Bern, Centre Alexis Vautrin (CAV), Service de Pathologie, This work was supported by grants from the French Institut National du Cancer, the French Projets Hospitaliers de Recherche Clinique program, the European Connective Tissue Cancer Network, the Curie Institute, the Bergonie Cancer Institute and l’INSERM. The construction of the human BAC array was supported by grants from the Carte d’Identité des Tumeurs program of the French Ligue Nationale Contre le Cancer., Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Bergonié [Bordeaux], UNICANCER-UNICANCER-Université Bordeaux Segalen - Bordeaux 2, Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Descartes - Paris 5 (UPD5), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: Nature Medicine
Nature Medicine, 2010, 16 (7), pp.781-787. ⟨10.1038/nm.2174⟩
Nature Medicine, Nature Publishing Group, 2010, 16 (7), pp.781-787. ⟨10.1038/nm.2174⟩

مصطلحات موضوعية: Oncology, Male, medicine.medical_specialty, Pathology, Multivariate analysis, Expression Signature, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.BBM.BM] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology, General Biochemistry, Genetics and Molecular Biology, Disease-Free Survival, Metastasis, 03 medical and health sciences, 0302 clinical medicine, [SDV.CAN] Life Sciences [q-bio]/Cancer, Internal medicine, Neoplasms, [SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN], Medicine, Humans, Neoplasm Metastasis, Gene, 030304 developmental biology, Aged, 0303 health sciences, Training set, Genome complexity, business.industry, Gene Expression Profiling, Sarcoma, [SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology, General Medicine, Middle Aged, medicine.disease, Prognosis, 3. Good health, Gene expression profiling, Treatment Outcome, 030220 oncology & carcinogenesis, [SDV.BBM.GTP] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN], Female, business, Forecasting

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04a37ef1861783311778be21b9d74614Test
https://www.hal.inserm.fr/inserm-02438669Test

المؤلفون: Worta McCaskill-Stevens, Malou Vicente, Michael Andersson, E. Quinaux, Steven Olsen, Martine Piccart-Gebhart, Richard D. Gelber, Bo Nordenskjöld, Angelo Di Leo, Prudence A. Francis, Raimund Jakesz, Armando Santoro, Evandro de Azambuja, Jan Demol, J. Dewar, Ana Lluch, John Crown, Jorge Gutiérez, Mireia Margeli Vila, Rosa Giuliani

المساهمون: Institut Jules Bordet [Bruxelles], Faculté de Médecine [Bruxelles] (ULB), Université libre de Bruxelles (ULB)-Université libre de Bruxelles (ULB), National Cancer Institute, National Institutes of Health, Peter MacCallum Cancer Centre and St Vincent's Hospital, Australian New Zealand Breast Cancer Trials Group, Australian New Zealand Breast Cancer Trials Group, International Breast Cancer Study Group, International Drug Development Institute, St. Vincent's Hospital, St. Vincent's Hospital, Sydney, Br.E.A.S.T. Data Centre, Medical Oncology Unit, S. Camillo-Forlanini Hospital, Universitetssjukhuset, Oncology, Clinica Las Condes, Department of Oncology, The Finsen Centre, Copenhagen University Hospital, Hospital Germans Trias I Pujol, University of Vienna, General Hospital, Heilig Hart Ziekenhuis, Sir Charles Gairdner Hospital, Istituto Clinico Humanitas [Milan] (IRCCS Milan), Humanitas University [Milan] (Hunimed), Hospital Clinico Universitario, Hospital Clínico Universitario, Sanofi-aventis, Sanofi-Aventis, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute [Boston], Sandro Pitigliani Medical Oncology Unit, Hospital of Prato

المصدر: Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, Springer Verlag, 2009, 119 (1), pp.145-153. ⟨10.1007/s10549-009-0512-0⟩

مصطلحات موضوعية: Adult, Oncology, Cancer Research, medicine.medical_specialty, Node-positive, medicine.medical_treatment, Antineoplastic Agents, Breast Neoplasms, Docetaxel, Disease-Free Survival, Body Mass Index, Metastasis, 03 medical and health sciences, BMI, 0302 clinical medicine, Breast cancer, Internal medicine, medicine, Humans, Obesity, Aged, Retrospective Studies, 030304 developmental biology, 2. Zero hunger, 0303 health sciences, Chemotherapy, business.industry, Cancer, Retrospective cohort study, Middle Aged, Prognosis, medicine.disease, 3. Good health, Surgery, Adjuvant chemotherapy, Treatment Outcome, Chemotherapy, Adjuvant, Doxorubicin, Lymphatic Metastasis, 030220 oncology & carcinogenesis, Female, Taxoids, Breast disease, business, Body mass index, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cec02dfcc158b7393695adb4f3e3fc3cTest
https://hal.archives-ouvertes.fr/hal-00535391/file/PEER_stage2_10.1007%2Fs10549-009-0512-0.pdfTest